Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Mesenchymal Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00001217
What this trial is testing

Osteosarcoma Study #2: A Randomized Trial of Pre-Surgical Chemotherapy vs. Immediate Surgery and Adjuvant Chemotherapy in the Treatment of Non-Metastatic Osteosarcoma. A Pediatric Oncology Group Phase III Study

Who this might be right for
Osteosarcoma
National Cancer Institute (NCI) 260
Early research (Phase 1)Active Not RecruitingNCT03478462
What this trial is testing

Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas

Who this might be right for
Pediatric Solid TumorPediatric LymphomaPediatric Brain Tumor+5 more
Cellectar Biosciences, Inc. 30
Not applicableActive Not RecruitingNCT03908788
What this trial is testing

Detection of the Emergence of RAS (Rat Sarcoma Viral Oncogene Homolog) Mutations in Circulating DNA (Deoxyribonucleic Acid) in Patients With mCRC (Metastatic Colorectal Cancer) During Treatment With Anti-EGFR (Epidermal Growth Factor Receptor) Therapy

Who this might be right for
Metastatic Colorectal Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 130
Testing effectiveness (Phase 2)Study completedNCT00002003
What this trial is testing

Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas

Who this might be right for
Lymphoma, Non-HodgkinHIV Infections
Lederle Laboratories
Early research (Phase 1)Study completedNCT02180698
What this trial is testing

TLR4 Agonist GLA-SE and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma That Is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Stage III Adult Soft Tissue SarcomaStage IV Adult Soft Tissue Sarcoma
Fred Hutchinson Cancer Center 16
Testing effectiveness (Phase 2)Study completedNCT00047021
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or Lymphoma

Who this might be right for
LeukemiaLymphoma
Case Comprehensive Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT01125800
What this trial is testing

A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB

Who this might be right for
MedulloblastomaRhabdomyosarcomaNeuroblastoma+3 more
Novartis Pharmaceuticals 76
Testing effectiveness (Phase 2)Study completedNCT02423863
What this trial is testing

In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol®

Who this might be right for
MelanomaHead and Neck CancerSarcoma+1 more
Oncovir, Inc. 26
Not applicableStudy completedNCT04123158
What this trial is testing

MYometrial Lesion UltrasouNd And mRi

Who this might be right for
Sarcoma Uterus
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 2,353
Testing effectiveness (Phase 2)Looking for participantsNCT01804634
What this trial is testing

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Who this might be right for
Refractory and/or Relapsed Metastatic Solid Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60
Testing effectiveness (Phase 2)Ended earlyNCT02609984
What this trial is testing

Study to Compare the Safety and Efficacy of CMB305 With Atezolizumab to Atezolizumab Alone in Participants With Sarcoma (IMDZ-C232/V943A-002)

Who this might be right for
SarcomaMyxoid/Round Cell LiposarcomaSynovial Sarcoma+4 more
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 89
Not applicableStudy completedNCT03025438
What this trial is testing

Cytological Diagnosis of Hepatic Angiosarcoma and Its Histopathologic Correlation

Who this might be right for
Hepatic Angiosarcoma
National Taiwan University Hospital 13
Not applicableActive Not RecruitingNCT06743958
What this trial is testing

Prehabilitation in Childhood Soft Tissue or Bone Sarcomas

Who this might be right for
Soft Tissue Sarcoma of the Lower ExtremityBone Tumor of the Lower ExtremityChildhood and Adolescent Cancer
Technical University of Munich 16
Not applicableAvailableNCT06617572
What this trial is testing

Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel

Who this might be right for
Synovial SarcomaMyxoid Liposarcoma
USWM CT, LLC
Not applicableStudy completedNCT06613230
What this trial is testing

Improved Early Diagnosis in Female Pelvic Cancer With OC Detect

Who this might be right for
Ovarian CancerEndometrial CancerBreast Cancer+3 more
Region Skane 490
Early research (Phase 1)UnknownNCT03002805
What this trial is testing

CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progressed on Doxorubicin

Who this might be right for
Sarcoma
CBA Research 46
Early research (Phase 1)Study completedNCT03157167
What this trial is testing

An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)

Who this might be right for
Kaposi SarcomaHIV Infections
Navidea Biopharmaceuticals 15
Large-scale testing (Phase 3)Looking for participantsNCT06881992
What this trial is testing

Ersodetug in Patients With Tumor Hyperinsulinism

Who this might be right for
Tumor Hyperinsulinism (Tumor HI)
Rezolute 16
Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Large-scale testing (Phase 3)Active Not RecruitingNCT03914612
What this trial is testing

Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer

Who this might be right for
Endometrial Clear Cell AdenocarcinomaEndometrial Dedifferentiated CarcinomaEndometrial Endometrioid Adenocarcinoma+13 more
National Cancer Institute (NCI) 813
Next Page